The optical detection of retinal ganglion cell damage by Morgan, James et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/99605/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Morgan, James, Tribble, James, Fergusson, James, White, Nicholas and Erchova, Irina 2017. The
optical detection of retinal ganglion cell damage. Eye 31 (2) , pp. 199-205. 10.1038/eye.2016.290
file 
Publishers page: http://dx.doi.org/10.1038/eye.2016.290 <http://dx.doi.org/10.1038/eye.2016.290>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
 1 













Address for Correspondence 
 
James E Morgan 




















We provide an overview of developments in the use OCT imaging for the detection of retinal 
ganglion cell damage in vivo that avoid use of any exogenous ligands to label cells. The 
method employs high resolution OCT using broad spectral light sources to deliver axial 
resolution of under 5 microns. The resolution approximates that of cellular organelles, which 
undergo degenerative changes that progress to apoptosis as a result of axon damage. These 
degenerative changes are manifest as the loss of retinal ganglion cell dendrites and 
fragmentation of the subcellular network of organelles, in particular, the  mitochondria that 
support dendritic structure. 
 
These changes can alter the light scattering behaviour of degenerating neurons. Using OCT 
imaging techniques to identify these signals in cultured neurons, we have demonstrated 
changes in cultured cells and in retinal explants. Pilot studies in human glaucoma suggest 
that similar changes are detectable in the clinical setting. 
 
High resolution OCT can be used to detect optical scatter signals that derive from the retinal 
ganglion cell layer and are associated with neuronal damage. These findings suggest that 
OCT instruments can be used to derive quantitative measurements of retinal ganglion cell 
damage. Critically, these signals can be detected at an early stage of retinal ganglion cell 
degeneration when cells could be protected or remodeled to support visual recovery. 
 





Our understanding of retinal ganglion cell (RGC) death in diseases such as glaucoma and 
optic neuropathy has been transformed in recent years
1
. For the most part, RGC death 
occurs by apoptosis
2
, which is the culmination of a series of active cellular events involving 
organelle disruption. As with most chronic neuronal degenerative conditions these changes 
are preceded by a prolonged period of neuronal damage. In RGCs this is manifest as pruning 
of the processes (dendrites) that convey signals from outer retina to the RGC
3-6
. Dendrites 
process and integrate signals from bipolar cells to provide the physiological basis for the 
receptive field of the retinal ganglion cell- the areas in the visual field, which when stimulated 
will activate a single RGC. The relationship between the integrity of the receptive field and the 




Animal models of  glaucoma or optic neuropathy have shown a similar pattern of RGC 
degeneration in which peripheral dendrites are preferentially damaged. Dendrites that are 
closer to the cell body (primary and secondary dendrites) are preserved in late stages of 
disease and 
3,8
 remain discernible in eyes with end stage RGC damage{ Naskar:2003ve}.  
While the majority of data showing these changes are based on rodent models of disease 





studies in primates have shown that these early dendrite pruning are associated with reduced 




The presence of diseased but viable cells presents an attractive target for detecting early 
RGC damage
11
. RGC dendrites provide a particularly sensitive readout of neuronal 
degeneration in cell and tissue based studies. Recent work in explant models of RGC 
degeneration has highlighted the possibility that these cells can be targeted to re-establish 
connections with the outer retina to provide a neural substrate for the restoration of vision in 
diseases such as glaucoma 
11,12
. The challenge is to determine whether these changes can 
be discerned using non-invasive techniques that are suitable for clinical application.  This 
paper presents data from a number of studies based on OCT imaging, which suggest that this 











Clinical imaging for the  detection of retinal ganglion cell damage  
Imaging of the retinal and optic nerve has been transformed by the development of, laser 
based techniques that provide fast acquisition, high-resolution images of the eye. Two 
methods are of particular interest. Fluorescence imaging has shown particular promise for the 
in vivo detection of RGC degeneration
13,14
 but this remains restricted to the use of rodent 
models in which RGCs have been induced to fluoresce by genetic engineering. A more 
practical application of fluorescence imaging for the detection of RGC damage has used 
fluorescently tagged Annexin V antibody fragment to label cells that are in the early stages of 
the apoptotic pathway
15,16
. The so-called DARC (Detection of Apoptosing Retinal Ganglion 
Cells) technique has achieved notable success in animal models in which RGC apoptosis has 
been induced by axon crush by showing a clear increase in the numbers of tagged cells 
following axotomy
17
.  The technique is currently under evaluation to determine the rate of 
RGC apoptosis in clinical studies. The clinical utility of DARC will depend, to some extent, on 
precise quantification of the number of remaining RGCs. In experimental studies, the Annexin 
tag has been delivered by intravitreal injection 
17
: for clinical evaluation a topical delivery 
method would be ideal. 
 
Coherence based imaging 
Optical coherence tomography (OCT) has become a staple clinical tool to image  retinal 
layers in healthy and diseased tissue. The resolution of OCT instruments now falls within the 
scale of degenerating cellular organelles  (<5um)
18
 and possibly neuronal activity
19
. In the 
pre-apoptotic stages (Figure1), mitochondrial networks fragment, preceding the nuclear 
disintegration which marks an irreversible commitment to cell death
20
. While nuclear 
fragmentation
21
 generates significant light scatter it could only be used as an index of cell 
death rather than disease. By contrast, mitochondrial fragmentation is a conveniently early 
feature of apoptosis which could be used to highlight regions where cells are diseased but not 
fully committed to cell death.  Work in other areas- for example scatter dependent cell sorting 
has suggested that changes on this scale can generate detectable levels of optical scatter
22
. 
Low coherence imaging methods have also been developed for the in vivo detection of 
dysplastic cellular changes most likely as a result of changes to the light scattering properties 
of cell nuclei
23
. We have previously reported mitochondrial changes in the dendritic trees of 
mice with experimental (OPA1) related optic neuropathy
24
. Early analysis of change in the 
mitochondrial distributions in the dendrites of midget cells in human glaucoma suggests that 
fragmentation and aggregation may offer feasible optical targets to generate changes in 
optical scatter that could be detected using OCT (Figure 2). However, the mitochondria within 
these dendrites will alter their distribution as a function of disease
25
 to  generate  changes in 
optical (light) scatter that should fall within the resolution limit of high resolution OCTs. It could 
reasonably be argued that the availability of such high resolutions with next generation OCT 
devices would allow the delineation (and counting) of  individual retinal ganglion cells which 
would be of greater clinical value. Unfortunately, the contrast that demarcates cell boundaries 
 5 
requires an order of magnitude increase in sensitivity and clinical studies would be severely 
impacted by eye movement artifacts.   
 
Resolution limits and definitions 
For a proof of principle, the application of these techniques in the laboratory setting is 
simplified because exposure times can be prolonged, sample movement minimized and the 
aperture and optics of the test system finely controlled. A key advantage of OCT imaging is 
that it decouples axial and transverse resolutions
26
. In confocal imaging systems both are 
hostage to the aperture and aberrations of the eye. By contrast, with OCT, the axial resolution 
is limited by spectral spread of the light source. Although the terms ‘laser’ is often used to 
describe the illuminating beam in an OCT, the light sources are super luminescent diodes, 
which deliver a spread of wavelength, approximately centred on a midpoint (mean) 
wavelength.  Clinically used OCTs typically use light with a mean wavelength in the range 
800-1040nm with a spectral spread of 50-80nm. The axial resolution is inversely related to 




).( λ, mean wavelength, Δλthe spectral width). 
It can be seen that an increase in the spectral spread (Δλ), will reduce the minimum 
resolvable dimension (lc), resulting in an increase in the resolution. For example, OCTs used 
for experimental work (e.g. Phoenix Research Laboratories) have a spectral spread of the 
order of 140nm, to provide a theoretical axial resolution of approximately 3um). Until recently, 
cost has been a limiting factor for the use of wider spectral light sources (e.g. Titanium 
Sapphire lasers). The wider availability of multiplexed diodes whose wavelength output can 
be approximated to a Gaussian distribution with a large spectral spread (> 100 nm) will help 
in bringing higher resolution OCT into the clinical domain. When the resolution is matched in 
transverse and axial directions it is called isotropic- the ideal state for an imaging device. For 
most OCTs the axial resolution exceeds the transverse resolution since the latter is affected 
by aberrations of the human eye. These can be overcome using adaptive optics to yield high-
resolution isotropic resolutions
27
. These OCT systems are however, complex and with limited 
views of the retina and optic nerve which can limit clinical application. 
 
Light scatter during neuronal degeneration 
Since OCTs can potentially detect signals from objects approximating the dimension of 
subcellular organelles, we reasoned that they could be used to detect signals that correlate 
with the time course of neuronal degeneration. OCT images contain noise (speckle) arising 
from use of a laser as a light source but also from interference with multiple back scattering 
objects in a region of interest. The sources of speckle in OCT imaging has been covered in 
depth by Schmitt et al. 
28
 who usefully differentiated speckle into that containing  information 
 6 
relevant to the imaged objects from speckle that degraded the image quality (Figure 3a).    
We therefore developed methods to extract useful measurements of optical texture from the 
speckle associated with OCT images. The signal to support this analysis combines optical 
scatter from changes in the tissue under examination, speckle due to forward light scatter and 
noise in the imaging system and detector. These signals are usually removed by image 
processing  in commercial OCTs to facilitate segmentation of retinal boundaries.  
 
We therefore constructed a custom OCT coupled to a standard compound microscope to 
examine changes in texture that occur in both cultured retinal ganglion cells and retinal 
explants
29
(Figure 3b). The OCT used a Femtosecond Integral Ti:Sapphire laser with a high 
bandwidth of 140 nm to provide a theoretical bandwidth of 3um. The examination of single 
cells over time allowed the detection of subcellular changes that occur once cell death has 
been initiated. We selected RGC5 cells which at the time of the study were thought to provide 
a useful mimic of retinal ganglion cells. Subsequent analysis has shown that these are most 
likely a murine neuronal cell line which can express some markers shared by retinal ganglion 




RGC5 neuronal degeneration over time 
Histological examination confirmed mitochondrial aggregation and caspase activation in 
RGC5 cell death following the initiation of apoptosis by the addition of staurosporine
29,31
. The 
details of the mathematical modeling are described in details elsewhere
29
. In brief, the image 
was parameterized using 65 features, which were then selected on the basis of the accuracy 
with which they correlated with culture stage. The selection of these dimensions was 
hypothesis free and based on the (unprocessed) spectral signal from the OCT. The aim of 
these pilot experiments was to determine if texture features could be detected that correlated 
with the stage of degeneration in the RGCs and allowed the effective discrimination of healthy 
from dying cells. Images were taken at regular intervals of the same region of interest, prior to 
RGC5 apoptosis (as demonstrated by Tunel staining).  
 
We employed a Gaussian Mixture Model analysis to identify those variables related to image 
texture which corresponded the degree of cellular degeneration. We aggregated these 
measures into a single dimensionless coefficient – the Texture Index (TI) to plot against time 
following the administration of staurosporine. These parameters were then fixed and used to 
analyse separate populations of RGC5 cells following the administration of staurosporine and 
agent that can induce apoptosis. We observed a progressive shift in the TI within 20 minutes 
of staurosporine, prior to the onset of significant apoptosis (Figure 4). These observations 
were consistent with a change in light scatter as a function of neuronal degeneration.   
 
We next examined whether similar signals could be detected in in retinal explants. Explants 
provide an excellent model for the study of retinal ganglion cell degeneration since RGC 
 7 
degeneration is initiated by axotomy during specimen preparation
32
. We have analysed the 
changes in RGC dendritic structure using particle-mediated fluorescent labeling (Diolistics), 
showing that dendrite pruning occurs within 6 hours of axotomy. These changes are shown in 
figure 5 demonstrating that RGC dendrites are extensively pruned during the first 3 days of 
culture, 
12
, supporting their use as a model of dendrite degeneration. For the purposes of this 
study, we randomly selected regions of interest from the inner plexiform layer (IPL) and 
subjected these to texture analysis using similar parameter settings as used for the RGC5 
study.  Retinal explants were scanned enfaces, retinal ganglion cell side up, and maintained 
their optical clarity throughout the experiment. The TI showed a monotonic increase as a 
function of time consistent with observations in single cell data (Figure 6). 
 
Human studies 
Subsequent studies determined whether texture analysis could confer any benefit in the 
detection of glaucoma at an early stage in the disease
33
. The experimental OCT device, 
which had a lower spectral spread and longer wavelength compared with the RGC5 study 
(NP photonics ASE light source, 1024nm, FWHM 80nm, theoretical axial resolution 7um), 
was connected to a clinical scanner and macular scans taken of patients with early/moderate 
glaucoma (14 normal, 10 glaucoma). As for the explant studies, texture signatures were 
extracted from the inner plexiform layer but in addition these were passed to a Supported 
Vector Machine (SVM) methods for classification to determine if they could confer any 
additional diagnostic precision in the discrimination of patients with early/moderate glaucoma.  
Several images processing steps were required to eliminate artifacts arising from micro 
saccades
34
. A small but potentially useful improvement in diagnostic accuracy (up to 4%) 
could be seen when texture features were added to more conventional parameters used to 






Texture analysis for the detection of retinal ganglion cell disease 
Our studies and the work of others support the use of texture analysis to quantify some 
dimensions of neuronal health taking RGCs as a specific example. The cell-based studies 
were performed with a high resolution OCT employing broad spectral light sources. Since the 
costs of these light sources have reduced substantially their use in the clinical setting is to be 
anticipated. All studies were conducted on custom OCTs in which all stages of image 
processing were known; this is not necessarily the case with commercially available devices, 
which could limit further clinical application of this approach. 
  
Out data suggest that texture measurements and indices could be derived if OCT image 
filtering and segmentation were undertaken as suggested in figure 7. In this model, unfiltered 
data is stored and processed to derive texture data  in one analytic pathway and filtered data 
 8 
passed to another to segment retinal layers and define regions of interest. The texture scores 
can then be aligned to the segmented images to provide an index of neuronal health for 
selected retinal layers. In the context of studying RGC health we suggest the IPL as an 
informative region of interest. It is clear that this technique has potential for the quantification 
of cellular health in other retinal layers, for example the photoreceptor layer for patient at risk 







Overview of the sequence of cellular changes that precede apoptotic (programmed) cell 
death. ‘Disease’ covers changes that are reversible. ‘Death’ covers the point at which the 
cells commit to cell death. DARC: detection of apoptosing retinal ganglion cells. 
 
Figure 2 
Serial block face scanning electron microscope reconstruction images of human midget RGC 
from a normal and glaucomatous eye. The processes in the glaucomatous eye are reduced 
and mitochondria show aggregation within the remaining dendrite structure. Each RGC 
serially sectioned at 100nm. Scale 10 um. 
 
Figure 3a 






Origin of scatter (speckle signal) shown the interaction of forward and back scattering of light 





Gaussian Mixture Model analysis of early stages of apoptosis. Cell classification was based 
at each time point on the basis of texture analyses. A progressive shift in the Texture Index 
(TI) defined as before was observed within 20 min of the administration of staurosporine. 





Sholl plots representing the complexity of RGC dendritic trees as a function of time in culture 
for murine retinal explants. The arrow indicates the leftward shift in the distributions as a 





Changes in texture index as a function of time for murine retinas maintained in culture. OCT 
measurements were taken from the IPL within 1 hour of explant preparation. The texture 
index shows a steady increase with time, changing as early as 10 minutes of culture time. 











Scheme showing how OCT data can be separated into filtered data for the detection of retinal 
boundaries and unfiltered data for texture analysis. The two analyses can be merged to 
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